Pulse Biosciences (PLSE) Cash from Investing Activities (2015 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Cash from Investing Activities of -$105000.0 in Q4 2025, down 69.35% quarter-over-quarter from -$62000.0 in Q3 2025, and down 98.11% on a YoY basis from -$5.6 million in Q4 2024.
Pulse Biosciences (PLSE) Cash from Investing Activities (2015 - 2025) Analysis & Trends
Pulse Biosciences' Cash from Investing Activities history runs 11 years deep, the most recent figure standing at -$105000.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities fell 98.11% year-over-year to -$105000.0; the TTM figure through Dec 2025 stood at -$335000.0 (down 168.0% YoY), while the FY2025 annual figure was -$335000.0, down 168.0% from the prior year.
- Cash from Investing Activities was -$105000.0 for Q4 2025 at Pulse Biosciences, down from -$62000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $7.9 million in Q1 2021 to a low of -$279000.0 in Q1 2022.
- Historically, Cash from Investing Activities has averaged $329050.0 across 5 years, with a median of -$44000.0 in 2023.
- The sharpest annual moves came in 2021 and 2025: Cash from Investing Activities surged 99.3% in 2021, then plunged 800.0% in 2025.
- A 5-year view of Cash from Investing Activities shows it stood at -$134000.0 in 2021, then soared by 69.4% to -$41000.0 in 2022, then fell by 4.88% to -$43000.0 in 2023, then declined by 23.26% to -$53000.0 in 2024, then sank by 98.11% to -$105000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$105000.0 (Q4 2025), -$62000.0 (Q3 2025), and -$123000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | -105,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -105,000.00 |
| Dec 31, 2025 | -105,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Sep 30, 2025 | -62,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -123,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Mar 31, 2025 | -45,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Dec 31, 2023 | -43,000.00 |
| Sep 30, 2023 | -23,000.00 |
| Sep 30, 2023 | -23,000.00 |